Article Information
History
- March 6, 2023.
Article Versions
- Version 1 (November 4, 2022 - 15:26).
- Version 2 (November 9, 2022 - 14:13).
- Version 3 (December 23, 2022 - 02:43).
- You are viewing Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- 1Department of Electrical and Computer Engineering, McGill University, Montréal, QC, Canada
- 2Pharmacology-physiology Department, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Saguenay, QC, Canada; Centre intégré universitaire de santé et de services sociaux du Saguenay-Lac-Saint-Jean, Saguenay, QC, Canada; CRCHUS, Sherbrooke, Canada
- 3The Meakins-Christie Laboratories at the Research Institute of the McGill University Heath Centre Research Institute, & Department of Medicine, Faculty of Medicine, McGill University, Montréal, QC, Canada
- 4Mila, Quebec AI Institute, Montréal, QC, Canada
- ↵†Co-corresponding Authors: Amin Emad, 755 McConnell Engineering Building, 3480 University Street, Montreal H3A 0E9, Canada, Email: amin.emad{at}mcgill.ca, Simon Rousseau, RI-MUHC, E M3.2244, 1001 Décarie, Montréal H4A 3J1, Canada, Email: simon.rousseau{at}mcgill.ca
↵* These authors contributed equally.
Posted March 06, 2023.
A circulating proteome-informed prognostic model of COVID-19 disease activity that relies on routinely available clinical laboratories
